Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Uncategorized » Blog article: Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

This Article was Written September 11th, 2009

Powered by Gregarious (39)

Are Prostate Needle Biopsies Predictive Of The

Laterality Of Significant Cancer And Positive

Surgical Margins?

UroToday.com - In the online edition of the British Journal of Urology International, Dr. Rodrigo Frota presents the single surgeon laparoscopic radical prostatectomy (LRP) experience of Dr. Inderbir Gill. The study is a retrospective review with the intent of correlating preoperative needle biopsy and final specimen pathological data to determine if the laterality of a positive biopsy should influence the surgeon’s decision for ipsilateral nerve-sparing.Data included 490 LRP patients operated on between 2002 and 2006. None had received androgen-deprivation therapy and all had clinically localized prostate cancer (CaP). Prostate biopsy specimens were all internally reviewed and on prostatectomy analysis cancer volume was defined as low when it was <0.5cc, medium when between 0.5 and 2.0cc and extensive when >2.0cc. A focal positive surgical margin (PSM) was defined as a solitary site of malignant cells at any inked margin, and extensive PSM as multiple sites of involvement. Significant CaP in the specimen was defined as medium or extensive volume (>0.5cc) or any Gleason grade 4. The dominant biopsy side was defined as the only prostate lobe with disease for unilaterally positive biopsy cases and the lobe with the most positive biopsy cores for bilateral cases.

The median number of prostate biopsies performed per patient was 10.3 and the median number of cores positive for CaP was 2.84. Unilateral and bilateral nerve-sparing was performed in 14% and 59% of patients, respectively. Extracapsular extension (ECE) was found in 11 men (23%) with bilateral ECE in 51 men (10%). In patients with cancer only in the right prostate lobe on biopsy, 10% had a PSM or ECE on the left lobe. When CaP was only present in the left lobe on biopsy, PSM, ECE or significant CaP in the right lobe on final pathology was found in 12%, 8%, and 7%, respectively. Final Gleason score was unchanged from biopsy in 59%, upgraded in 35% and downgraded in 6%. A PSM was found in 21%, but in only 11% if intraoperative TRUS guidance was used. Most PSMs were apical (60%).

For unilaterally positive biopsies, concordance with laterality of any CaP on prostatectomy was 19% on the right and 12% on the left side. Thus only minor agreement existed between biopsy laterality and laterality of any CaP on final prostatectomy pathology. There was only minor agreement between biopsy laterality and laterality of significant CaP on final pathology. The number of prostate biopsy cores taken did not matter in influencing the laterality with final specimen pathology. Only minor agreement existed between laterality of a positive biopsy and laterality of PSMs.

In patients with dominant CaP in the right lobe on biopsy, a PSM occurred on the same side in 58%, but in 42% it occurred on the left side. If the left lobe had the dominant CaP on biopsy, a PSM occurred on the right side in 49% and on the left side in 39%. Thus only a minor correlation exists between laterality of CaP on prostate biopsy and laterality of significant CaP on final prostatectomy specimen.

Frota R, Stein RJ, Turna B, Kamoi K, Lin YC, Magi-Galluzzi C, Aron M, Gill IS
BJU Int. 2009 Jul 2. Epub ahead of print.
doi:10.1111/j.1464-410X.2009.08648.x

Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2009 - UroToday

Powered by Gregarious (39)

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    New Urine Test Better Detects Prostate Cancer

  • An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.The researchers say a
  • Privacy Policy

  • IsoRay Medical, Inc. Privacy Policy IsoRay Medical, Inc. is committed to protecting your privacy.  This Privacy Policy (this "Policy") describes certain policies of IsoRay Medical, Inc. and its affiliates (“IsoRay,” “we” or “us”) with respect to its collection and use of certain information.  This Policy applies to personal information collected by us
  • Urologic Oncology Institute Launched To Offer Multi-Disciplinary Care, Personalized Treatments To Patients

  • Urologic Oncology Institute Launched To  Offer Multi-Disciplinary Care, Personalized Treatments To Patients UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers. The Institute of Urologic Oncology at UCLA challenges the traditional model of academic departments operating independently of each other,
  • Research shows that soy decreases the risk of breast and prostate cancers

  • A new soy protein-packed, low-fat, high-fiber cereal meets the requirements for three different FDA health claims and leaves you feeling full so you won't be tempted to eat again until lunch.University of Illinois scientist Soo-Yeun Lee has a recipe for just such a cereal, one that's passed the taste test
  • Chemo Break Benefits Some Men With Prostate Cancer

  • FRIDAY, Feb. 29 (HealthDay News) -- Some men with advanced prostate cancer can safely take a break from chemotherapy, says a study by researchers at the Oregon Health & Science University Cancer Institute.The study included 250 men with metastatic, androgen-independent prostate cancer -- disease that spreads from the prostate and
  • De Niro Beats Prostate Cancer Suit

  • A Los Angeles judge on Tuesday granted the actor's request to toss a lawsuit filed against him by an insurance company that claimed De Niro intentionally withheld that he had prostate cancer before the insurer signed on to cover one of his films. Fireman's Fund Insurance Co. insured the production of
  • Strikeout prostate cancer

  •  About one in six men is diagnosed with prostate cancer. If it's caught early, the cancer is almost 100-percent curable, but if it goes undetected, it can be deadly. So now a new campaign is raising money and getting guys attention . . . with America's favorite pasttime. As major league
  • All About Robot-Assisted Prostate Surgery

  • What Should You Know About FascinatingTreatment Option?By Matthew Schmitz, M.D., About.com GuideCreated: November 19, 2009About.com Health's Disease and Condition content is reviewed by the Medical Review BoardRobot-assisted prostate surgery is a relatively new treatment option for prostate cancer. So what do you need to know about this fascinating surgical option?How Does Robot-Assisted Prostate
  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes

  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes ScienceDaily (Jan. 2, 2009) — In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this
  • Contact

  • Lori Woods 350 Hills Street, Suite 106 Richland, WA 99354 Phone (509) 375-1202 Email: lwoods@isoray.com


  •  

    March 2010
    M T W T F S S
    « Jan    
    1234567
    891011121314
    15161718192021
    22232425262728
    293031